Cutaneous T-Cell Lymphoma (CTCL) Recruiting Phase 1 Trials for Brentuximab vedotin (DB08870)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02616965A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell LymphomaTreatment